Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2012's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on TEVA
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
- Dividends
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
Teva Pharmaceutical Industries (NY:TEVA)
Delayed:
39.38
-0.11 (0.28%)
Trade Now!
Previous Close
$39.49
52 Week High
$42.83
Open
$39.50
52 Week Low
$36.63
Day High
$39.55
P/E
N/A
Day Low
$38.89
EPS
$0.00
Volume
2,730,523
Friends, Peers and Foes
(?)
:
MYL
,
OGXI
,
WPI
,
PRX
,
IPXL
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
May 14, 2013 10:35 AM
Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 13, 2013 09:00 AM
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.5 Million Grant from Israel’s Office of the Chief Scientist
May 10, 2013 08:54 AM
Form 6-K TEVA PHARMACEUTICAL INDU For: May 08
May 9, 2013 05:43 PM
BMO Capital Starts Teva Pharma (TEVA) at Outperform
May 8, 2013 12:41 PM
Unusual 11 Mid-Day Movers 05/08: (TRMD) (AFFY) (SYNM) Higher; (FIO) (OCLR) (LIOX) Lower
May 8, 2013 11:55 AM
New Data Presented Demonstrates Ovulatory Effect of Teva Women’s Health’s Investigational 28-Day Oral Contraceptive
May 8, 2013 11:22 AM
Form 6-K TEVA PHARMACEUTICAL INDU For: May 08
May 8, 2013 09:31 AM
StreetInsider.com Pre-Open Movers 5/8: (ALXA) (LEDR) (WBMD) Higher; (FIO) (OCLR) (VCLK) Lower (more...)
May 8, 2013 09:03 AM
Alexza Pharmaceuticals (ALXA) Surges 45% on Deal with Teva
May 8, 2013 08:35 AM
Alexza Announces Conference Call to Discuss Agreement with Teva to Market ADASUVE® in the U.S.
View All Articles
May 2, 2013 07:02 AM
Teva Pharmaceutical (TEVA) Tops Q1 EPS by 2c
Feb 7, 2013 07:18 AM
Teva Pharmaceutical (TEVA) Misses Q4 EPS by 1c
Nov 30, 2012 07:02 AM
Teva Pharma (TEVA) Guides FY13 EPS, Revs Below Expectations
Nov 5, 2012 10:02 AM
Teva Pharma (TEVA) Promotes Allan Oberman to CEO; Americas CEO Marth to Step Down
Nov 1, 2012 07:07 AM
Teva Pharmaceutical (TEVA) Tops Q3 EPS by 3c; Guides In-Line
Aug 2, 2012 07:06 AM
Teva Pharmaceutical (TEVA) Reports In-Line Q2 EPS of $1.28
May 24, 2012 08:29 AM
Teva Pharma (TEVA) Sees Weaker FY12 Sales, EPS
May 9, 2012 06:36 AM
Teva Pharmaceutical (TEVA) Tops Q1 EPS by 3c, Sales Light
Feb 15, 2012 07:10 AM
Teva Pharmaceutical (TEVA) Tops Q4 EPS by 1c
Dec 21, 2011 08:56 AM
Teva (TEVA) CEO Issues FY12 EPS, Sales Outlook
View All Major News
May 9, 2013 05:43 PM
BMO Capital Starts Teva Pharma (TEVA) at Outperform
May 8, 2013 12:41 PM
Unusual 11 Mid-Day Movers 05/08: (TRMD) (AFFY) (SYNM) Higher; (FIO) (OCLR) (LIOX) Lower
May 8, 2013 09:31 AM
StreetInsider.com Pre-Open Movers 5/8: (ALXA) (LEDR) (WBMD) Higher; (FIO) (OCLR) (VCLK) Lower (more...)
May 8, 2013 09:03 AM
Alexza Pharmaceuticals (ALXA) Surges 45% on Deal with Teva
May 8, 2013 08:32 AM
Aeva Pharma (ALXA), Teva (TEVA) Enter Exclusive License for ADASUVE
May 3, 2013 03:43 PM
UPDATE: Monkeys Treated with Amgen (AMGN) Drugs More Likely to Survive Nuclear Attack; FDA Approves Use
May 2, 2013 07:02 AM
Teva Pharmaceutical (TEVA) Declares $0.32 Quarterly Dividend; 3.4% Yield
May 2, 2013 07:02 AM
Teva Pharmaceutical (TEVA) Tops Q1 EPS by 2c
May 1, 2013 05:47 PM
Trading Radar for 05/02: MGM Resorts (MGM), GM (GM), Kraft Foods (KRFT), athenahealth (ATHN) Report
May 1, 2013 06:42 AM
OncoGenex (OGXI) to Initiate OGX-427 Phase 2 in Combo with ABRAXANE
View All Reports
May 14, 2013 10:35 AM
Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 13, 2013 09:00 AM
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.5 Million Grant from Israel’s Office of the Chief Scientist
May 8, 2013 11:55 AM
New Data Presented Demonstrates Ovulatory Effect of Teva Women’s Health’s Investigational 28-Day Oral Contraceptive
May 8, 2013 08:35 AM
Alexza Announces Conference Call to Discuss Agreement with Teva to Market ADASUVE® in the U.S.
May 8, 2013 08:30 AM
Teva and Alexza Announce Teva's License to Market ADASUVE® in the U.S.
May 8, 2013 08:30 AM
Teva and Alexza Announce Teva’s License to Market ADASUVE® in the U.S.
May 6, 2013 10:45 AM
Teva Women’s Health to Present New Data at the 61st Annual Meeting of the American Congress of Obstetricians and Gynecologists
May 2, 2013 04:00 PM
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
May 2, 2013 07:01 AM
Teva Reports First Quarter 2013 Results
May 1, 2013 06:30 AM
OncoGenex Announces Plans for the Initiation of the Rainier™ Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer
View All Press Releases
May 10, 2013 08:54 AM
Form 6-K TEVA PHARMACEUTICAL INDU For: May 08
May 8, 2013 11:22 AM
Form 6-K TEVA PHARMACEUTICAL INDU For: May 08
May 6, 2013 01:21 PM
Form 6-K TEVA PHARMACEUTICAL INDU For: May 06
May 2, 2013 10:14 AM
Form 6-K TEVA PHARMACEUTICAL INDU For: May 02
May 2, 2013 07:53 AM
Form 6-K TEVA PHARMACEUTICAL INDU For: May 02
May 1, 2013 12:37 PM
Form 6-K TEVA PHARMACEUTICAL INDU For: Apr 30
Apr 29, 2013 10:58 AM
Form 6-K TEVA PHARMACEUTICAL INDU For: Apr 29
Apr 25, 2013 10:27 AM
Form 6-K TEVA PHARMACEUTICAL INDU For: Apr 24
Apr 23, 2013 08:57 AM
Form 6-K TEVA PHARMACEUTICAL INDU For: Apr 23
Apr 17, 2013 08:56 AM
Form 6-K TEVA PHARMACEUTICAL INDU For: Apr 17
View All Filings
Entities mentioned with
TEVA
Earnings
|
View Related Stories »
Citi
|
View Related Stories »
Needham & Company
|
View Related Stories »
JPMorgan
|
View Related Stories »
Bank of America
|
View Related Stories »
Barclays
|
View Related Stories »
UBS
|
View Related Stories »
Morgan Stanley
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
Credit Suisse
|
View Related Stories »
Hedge Funds
|
View Related Stories »
Wells Fargo
|
View Related Stories »
Dividend
|
View Related Stories »
Notable Analyst Rating Changes
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
Standard & Poor's
|
View Related Stories »
Deutsche Bank
|
View Related Stories »
Paulson & Co. (PCI)
|
View Related Stories »
Goldman Sachs Conviction Buy List
|
View Related Stories »
Trading Radar
|
View Related Stories »
Piper Jaffray
|
View Related Stories »
Crude Oil
|
View Related Stories »
Morning Movers
|
View Related Stories »
Argus
|
View Related Stories »
Robert W Baird
|
View Related Stories »
Show More...
View All Entities